Beta Bionics, Inc. (BBNX) Share-based Compensation (2024 - 2026)
Beta Bionics (BBNX) posted Share-based Compensation of $5.4 million for Q1 2026, up 25.63% sequentially from $4.3 million in Q4 2025, and up 92.8% YoY from $2.8 million in Q1 2025.
Beta Bionics, Inc. (BBNX) Share-based Compensation (2024 - 2026) Analysis & Trends
Beta Bionics (BBNX) has 3 years of Share-based Compensation data on file, last reported at $5.4 million in Q1 2026.
- Quarterly Share-based Compensation rose 92.8% year-over-year to $5.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.0 million (up 142.45% YoY) and the FY2025 annual result came in at $16.4 million, up 156.64% from the prior year.
- Share-based Compensation advanced to $5.4 million in Q1 2026 per BBNX's latest filing, from $4.3 million in the prior quarter.
- The five-year high for Share-based Compensation was $5.4 million in Q1 2026, with the low at $1.4 million in Q1 2024.
- Average Share-based Compensation over 3 years is $3.1 million, with a median of $2.8 million recorded in 2025.
- Year-over-year, Share-based Compensation surged 220.15% in 2025 and surged 92.8% in 2026.
- Beta Bionics' Share-based Compensation stood at $1.6 million in 2024, then surged by 177.26% to $4.3 million in 2025, then rose by 25.63% to $5.4 million in 2026.
- Business Quant data shows BBNX's Share-based Compensation at $5.4 million in Q1 2026, $4.3 million in Q4 2025, and $4.5 million in Q3 2025.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.41 Mn |
| Mar 31, 2026 | 5.41 Mn |
| Dec 31, 2025 | 4.30 Mn |
| Dec 31, 2025 | 4.30 Mn |
| Sep 30, 2025 | 4.48 Mn |
| Sep 30, 2025 | 4.48 Mn |
| Jun 30, 2025 | 4.80 Mn |
| Jun 30, 2025 | 4.80 Mn |
| Mar 31, 2025 | 2.80 Mn |
| Mar 31, 2025 | 2.80 Mn |
| Dec 31, 2024 | 1.55 Mn |
| Dec 31, 2024 | 1.55 Mn |
| Sep 30, 2024 | 1.98 Mn |
| Sep 30, 2024 | 1.98 Mn |
| Jun 30, 2024 | 1.50 Mn |
| Jun 30, 2024 | 1.50 Mn |
| Mar 31, 2024 | 1.36 Mn |
| Mar 31, 2024 | 1.36 Mn |